This study tested the hypothesis that reciprocal communication occurs between macrophages and cultured human endometrial stromal cells and that this communication may contribute to the pathology of endometriosis. An endometrial stromal cell line (telomerase-immortalized human endometrial stromal cell [T-HESC]) was treated with macrophage-conditioned medium (CM) + estradiol þ progesterone. Macrophages were treated without or with T-HESC CM. DNA microarray identified 716 differentially expressed genes in T-HESCs in response to factors secreted by macrophages. Upregulated genes in T-HESC included interleukin 8 (IL-8)/chemokine (C-X-C motif) ligand 8 (CXCL8), matrix metalloproteinase 3 (MMP3), phospholamban, cysteine-rich angiogenic inducer 61 (CYR61), connective tissue growth factor (CTGF), tenascin C, and nicotinamide N-methyltransferase (NNMT), whereas integrin a-6 was downregulated. In contrast, 15 named genes were differentially expressed in macrophages in response to factors secreted by endometrial stromal cells. The data document reciprocal communication between macrophages and endometrial stromal cells and suggest that interaction with macrophages stimulates the expression of genes in endometrial stromal cells that may support the establishment of endometriosis.
Introduction
Although endometriosis is considered a benign disease, the implantation of endometrial tissue in the peritoneal cavity causes significant pain, debility, and infertility. 1, 2 It has been proposed that the immune system is faulty in women who develop endometriosis, 3, 4 and endometriosis is clearly an inflammatory disease. 1, 2 Bone marrow-derived cells are plentiful in endometriotic explants and in the peritoneal fluid of women with the disease, 5-7 yet the immune system fails to destroy endometrial cells in the peritoneal cavity of those women. The presence of cytokines, growth factors, and chemokines secreted by bone marrow-derived cells alters the peritoneal environment in endometriosis, and it has been proposed that these factors contribute to the development of endometriosis. [7] [8] [9] [10] [11] Yet, despite the abundance of macrophages and monocytes found in peritoneal fluid and endometriotic lesions of women with endometriosis, little is known regarding the role of these cells in the etiology of endometriosis or their interplay with endometrial cells. For endometriosis lesions to develop, endometrial cells must survive transit from the uterus to the peritoneal cavity in the absence of a blood supply, adhere to the peritoneum or ovarian surface, invade through the surface of the tissue to which they adhere, develop a new vascular supply, and grow. We hypothesize that communication between macrophages and endometrial cells can stimulate events associated with the development of endometriosis. More specifically, we theorize that interactions with macrophages tip the balance for endometrial cells from death to survival, adhesion, invasion, neovascularization, and growth. We have shown that monocytes and endometrial stromal cells communicate directly with each other. 12 The current study was designed to test the hypothesis that reciprocal communication occurs between macrophages and cultured human endometrial stromal cells and that this communication, translated to the in vivo state, may contribute to the pathology of endometriosis.
The current studies used cultured cells as a model system. These experiments were designed to model potential interactions between peritoneal macrophages and endometrial stromal cells that have mislocated to the peritoneal cavity, as well as the effect of decidualization on those interactions. Two cell lines were used, telomerase-immortalized human endometrial stromal cells (T-HESCs) 13 and U-937 macrophages. 14 Cell culture simplifies the study of the interactions among cells by limiting the numbers of cell types in the system. Moreover, cell culture allows examination of cell interactions in a controlled environment. These experiments analyzed the effect of factors secreted by macrophages on gene expression in T-HESCs, and the effects of factors secreted by T-HESCs on gene expression in macrophages. Genes that were differentially expressed in this study were compared to genes that were differentially expressed in endometriosis tissue 15 and in cultured endometrial cells exposed to factors secreted by monocytes. 12 
Methods and Materials Experimental Design
In experiment 1, T-HESCs were treated with vehicle or estradiol plus medroxyprogesterone acetate in the presence and absence of macrophage-conditioned medium (CM). In experiment 2, macrophages were treated under control conditions in the absence or presence of T-HESC-CM. Total RNA was extracted from the cells and gene expression was measured by DNA microarray and by real-time reverse transcriptaseÀ polymerase chain reaction (RT-PCR) for both experiments.
Cell Lines
American Type Culture Collection was the source for T-HESC and the U-937 monocytic cell line. Phenol red-free Dulbecco modified Eagle medium (DMEM)/F12 (Sigma, St Louis, Missouri) supplemented with 1% ITSþ (insulin, transferrin, selenious acid, bovine serum albumin, and linoleic acid; Becton Dickinson, Franklin Lakes, New Jersey), 10% charcoal-/dextran-treated fetal bovine serum albumin (FBS; HyClone, South Logan, Utah), 1% penicillin/streptomycin (Sigma), and 500 ng/mL puromycin (Sigma) were used for routine maintenance of T-HESCs. RPMI-1640 media (ATCC) supplemented with 10% charcoal-/dextran-treated FBS and 1% penicillin/streptomycin was used for routine maintenance of the U-937 cell line.
Preparation of the U-937 Macrophage-CM
For maintenance of the cell line, U-937 cells were grown as monocytes in the suspension in 10% FBS RPMI-1640 with pen/strep media until the cells covered 80% of the flask surface.The cells were treated with 32 nmol/L phorbol myristate acetate (PMA) for 48 hours to stimulate differentiation into macrophages. 16 The PMA-and FBS-containing medium was removed from the macrophages and the cells were rinsed with phosphate buffered saline (PBS). Fresh serum-free, phenol red-free DMEM/F12 media supplemented with 1% penicillin/ streptomycin was placed on the cells for 24 hours. The CM was collected, centrifuged, and filtered through a 0.2-mm filter and stored at À70 C until used as macrophage-CM. The U-937 macrophage CM was supplemented with 1% ITSþ and puromycin before use. The U-937 cells differentiated from the monocytic phenotype (suspension culture) to the macrophage phenotype (adherent and containing inclusion bodies) in response to PMA 16 (data not shown).
Preparation of T-HESC CM
T-HESCs were maintained in their routine media (phenol redfree DMEM/F-12 with 10% charcoal-/dextran-treated FBS supplemented as described above) until 80% confluent. The cells were rinsed with PBS and the DMEM/F-12 media was replaced with serum-free phenol red-free RPMI-1640 supplemented with 16.4 mmol/L L-glutamine, 10 mmol/L HEPES, and 1% penicillin/streptomycin for 24 hours, at which time the medium was removed from the T-HESCs, centrifuged, filtered through a 0.2-mm filter, and stored at À70 C until used as T-HESC CM.
Hormone and CM Treatments and RNA Extraction 12
For experiment 1, 4 flasks each of 3 separate passages of T-HESCs were cultured for 8 days. Two flasks of each passage were grown in the presence of 0.1% ethanol (vehicle control) and the remaining 2 flasks were treated with 10 À8 mol/L estradiol þ 10 À7 mol/L medroxyprogesterone acetate (E þ P; Sigma). 12, 13 Vehicle or E þ P was added to the cells every 48 hours when the media was changed. This dose and the duration of E þ P treatment induces a decidual-like reaction in cultured endometrial stromal cells. 13 Cells were serum starved beginning on day 6 of the experiment. U-937 macrophage CM was added to 1 flask of each treatment group (vehicle and EþP) on day 7. The remaining two flasks of cells were treated with non-conditioned control medium (serum-free, phenol redfree DMEM/F12 supplemented with 1% penicillin/streptomycin). To collect total RNA on day 8, the medium was removed from the T-HESCs, and 1 mL TRI reagent (Molecular Research Center, Cincinnati, Ohio) was added to each flask of rinsed cells. A cell scraper was used to suspend and homogenize the cells. Bromochloropropane (200 mL) and 3mol/L sodium acetate (60 mL) were added to the homogenate and the mixture was centrifuged to elicit phase separation. The aqueous phase of each sample containing the RNA was collected and purified on an RNeasy column (Qiagen, Valencia, California). The possibility of contamination of the RNA with DNA was eliminated by an on-column RNase-free DNase. The RNA quality and quantity were assessed using the RNA 6000 Nano LabChip in an Agilent Bioanalyzer (Agilent Technologies, Waldbronn, Germany).
For experiment 2, 2 flasks each of 3 separate passages of U-937 cells were grown in their routine RPMI-1640 media (ATCC) supplemented with 10% charcoal-/dextran-treated FBS and 1% penicillin/streptomycin until the cells covered 80% of the flask surface. The cells were treated with 32 nmol/L PMA for 48 hours to stimulate the differentiation of monocytes into macrophages. The macrophages were serum starved for 24 hours, then the medium was replaced with T-HESC CM or with non-conditioned control medium for 24 hours. Total RNA extraction and assessment of RNA were carried out as described above for T-HESCs.
DNA Microarrays
Applied Microarrays (Tempe, Arizona) was the source of the CodeLink Whole Human Genome Bioarrays 12, 15, 17, 18 used for the analysis of gene expression in experiments 1 and 2. In experiment 1, T-HESCs were treated with vehicle, E þ P, vehicle þ macrophage CM, or E þ P þ macrophage CM (n ¼ 3 passages/group, no samples were pooled). In experiment 2, U-937 macrophages were treated with non-CM or T-HESC CM (n ¼ 3 passages/group, no samples were pooled). Code-Link microarrays are spotted with single-stranded 30-mer oligonucleotide probes for 53 000 human genes/transcribed sequences. Total RNA was the starting material for the synthesis of biotinylated complementary RNA (cRNA) as described. 15 Biotinylated cRNA was hybridized with the CodeLink microarrays for 18 hours, and hybridized slides were processed and scanned as described. 15 GenePix Pro software (MDS, Inc, Toronto, Canada) was used to acquire the microarray images. Microarray data were aligned, background correction applied, and individual spots were associated with their gene identifiers using CodeLink software (Applied Microarrays). Acuity software (MDS, Inc) was used to obtain fold expression values. Statistical analysis of the microarray data, normalization of the expression of each gene to the median gene expression and of each slide to the 50th percentile of gene expression were carried out using Gene-Spring 7.3 software (Agilent, Santa Clara, California). Comparisons of differential gene expression in the current study were made to lists of differentially expressed genes in endometriosis tissue 15 and to cultured T-HESCs that had been treated with monocyte CM. 12 
Real-time RT-PCR
Real-time RT-PCR was used to confirm differential expression of selected genes identified by DNA microarray. Pre-designed primers and minor groove binding probes and TaqMan Gold reagents were obtained from Applied Biosystems (Foster City, California) as described. 12 Differences in expression of each gene of interest were calculated relative to the expression of an endogenous control, glyceraldehyde 3-phosphate dehydrogenase (GAPDH), a housekeeping gene. The qBase software 19 package was used to analyze real-time RT-PCR data.
Statistical Analyses
The GeneSpring 7.3 (Agilent) software package was used to analyze the DNA microarray data by analysis of variance (ANOVA). The multiple testing correction used the Benjamini and Hochberg false discovery rate. Approximately 5% of the identified genes would be expected to pass this restriction by chance. Real-time RT-PCR data were analyzed by ANOVA followed by Newman-Keuls Multiple Comparison Test using GraphPad Prism 4.0 software (GraphPad Software, San Diego, California).
Results
An increase in prolactin expression is considered a universal marker for decidualization. 13 Assessment of prolactin expression by real-time RT-PCR showed an increase from 3.04 + 0.7 in control conditions to 60.34 + 7.2 in the presence of E þ P. The cells also underwent phenotypic changes in response to E þ P as described with decidualization 13 (data not shown). The increase in prolactin expression and phenotypic changes in the presence of E þ P confirm the endometrial identity of the cell line of T-HESC. The presence of macrophage CM reduced prolactin expression to 1.0 + 0.3 in control conditions and 6.77
Statistical analysis demonstrated that the treatment of T-HESCs with macrophage CM resulted in 2-fold up-or downregulation of 716 named genes with P values of .05 or less and with expression values greater than 1. Of those genes, 644 responded to macrophage CM in the absence or presence of E þ P (Supplemental Table 1 ). The remaining 72 genes responded to E þ P but not to macrophage CM (Supplemental Table 2 ). The genes were sorted into 23 gene ontologies based on the categories of differential expression in response to macrophage CM ( Table 1) ; some of the ontologies were empty in the E þ P-only responding genes. The entire data set for all DNA microarrays in this study has been deposited in the National Center for Biotechnology Information Gene Expression Omnibus ([GEO]; www.ncbi.nlm.nih.gov/geo) as recommended by Minimum Information About a Microarray Experiment (MIAME) standards. 20 The data can be accessed through GEO Series accession number GSE19834.
Real-time RT-PCR was used to confirm the differential expression of selected genes. Treatment of cultured T-HESCs with macrophage CM significantly increased the expression of interleukin 8, also known as chemokine CXCL8 (IL8/ CXCL8); the presence of E þ P did not affect IL8/CXCL8 expression in the presence or absence of macrophage CM ( Figure 1A, B ). Treatment of cultured T-HESCs with macrophage CM significantly increased the expression of matrix metalloproteinase 3 (MMP3) as shown by both DNA microarray and by real-time RT-PCR. The presence of E þ P significantly reduced the upregulation of MMP3 expression caused by treatment with macrophage CM ( Figure 1C , D). Matrix metalloproteinase 1 (MMP1) showed a similar pattern of expression as MMP3 (Supplemental Table 1 ). In contrast, the expression of integrin a-6 (ITGA6) was significantly reduced by treatment with both E þ P and macrophage CM ( Figure  1E , F). The presence of macrophage CM stimulated a significant increase in the expression of phospholamban (PLN). The addition of E þ P reduced the expression of PLN to control levels ( Figure 1G , H).
The expression of cysteine-rich angiogenic inducer 61 (CYR61), also known as CCN1 (named for the first three members of the family, cyr61, ctgf, nov) was significantly increased in T-HESCs in the presence of macrophage CM. The addition of E þ P had no effect on control expression of CYR61/CCN1 but downregulated its expression in the presence of macrophage CM (Figure 2A, B) . The presence of macrophage CM stimulated a significant increase in the expression of connective tissue growth factor, also known as CCN2 (CTGF/CCN2). The addition of E þ P reduced the expression of CTGF/CCN2 to control levels ( Figure 2C , D). Treatment of cultured T-HESCs with macrophage CM significantly increased the expression of tenascin C (TNC) as shown by both DNA microarray and real-time RT-PCR. For tenascin, the presence of E þ P significantly reduced the upregulation of expression caused by treatment with macrophage CM (Figure 2E , F). Nicotinamide N-methyltransferase (NNMT) expression was significantly increased in T-HESCs treated with macrophage CM. The presence of E þ P caused a further increase in the expression of NNMT in cultured T-HESCs in the presence of macrophage CM ( Figure 2G, H) .
The genes that were differentially expressed in T-HESCs in response to treatment with macrophage CM (Supplemental Table 1 ) were compared to the genes that were shown to be differentially expressed in endometriosis in a previous study from our laboratory 15 using Access database and Excel to identify duplicates in the 2 gene lists. Forty-six genes appeared in both lists ( Table 2 ). The list of overlapping genes included 6% of each individual gene list ( Figure 3A ). Five genes from the group that appeared on both lists were in the group chosen for follow-up with real-time RT-PCR in T-HESCs described above (ITGA6, PLN, CYR61/CCN1, CTGF/CCN2, and NNMT).
The genes that were differentially expressed in T-HESCs in response to macrophage CM (Supplemental Table 1 ) were also compared to the genes that were differentially expressed in T-HESCs in response to monocyte CM as described in a previous study from our laboratory 12 using Access database and Excel to identify duplicates in the 2 gene lists. Under control conditions, 98 genes were differentially expressed in T-HESCs in response to treatment with either macrophage CM or monocyte CM (Supplemental Table 3 ).
Secreted factors synthesized by macrophages grown under control conditions that are expected to be responsible for stimulating differential gene expression in T-HESCs were identified by DNA microarray ( Table 3 ). The group of factors secreted by macrophages was compared to the list of factors secreted by monocytes reported previously. 12 There was substantial overlap of the factors secreted by monocytes with the factors secreted by macrophages ( Figure 3B ). Of the 58 factors secreted by monocytes, 54 were also secreted by macrophages. In contrast, there was less overlap of factors secreted by macrophages in that 54 of the 116 macrophage-secreted factors matched those of monocytes ( Figure 3B ). However, the overlap of differentially expressed genes in T-HESC in response to macrophage CM versus monocyte CM was not as great as the overlap of factors secreted by the 2 cell types ( Figure 3C ).
Treatment of U-937 macrophages with T-HESC CM resulted in the differential expression of 15 named genes that exhibited more than 2-fold difference (increase or decrease) compared to control and with P values of .05 or less (Table 4 ). Five genes that were upregulated in U-937 macrophages in response to treatment with T-HESC CM were also upregulated in T-HESCs treated with macrophage CM. These 5 genes were MMP3, metallothionein 1X, oxidized low-density lipoprotein receptor 1, tumor necrosis factor receptor superfamily member 21 (TNFR21), and inhibin b-A.
Discussion
The most important finding of this study is that reciprocal communication occurs between cultured endometrial stromal cells and macrophages. First, treatment of cultured endometrial stromal cells with macrophage CM resulted in changes in the expression of a large number of genes which indicates that macrophages secrete factors that act on endometrial stromal cells. Secretory activity increases dramatically when monocytes differentiate into macrophages, 16 and we identified a number of secreted factors from macrophages using DNA microarray. These secreted factors include cytokines, chemokines, growth factors, and other ligands, all of which may contribute to the changes in gene expression observed in cultured endometrial stromal cells. Endometrial stromal cells upregulate the expression of cytokines, chemokines, and other ligands in response to macrophage CM. These factors may act on macrophages and other cell types of an endometriosis lesion, and they may act in a paracrine manner on neighboring endometrial stromal cells. Genes in ontologies associated with cellular functions associated with the establishment of endometriosis such as cell survival (cell cycle/cell death ontology), adhesion, neovascularization (angiogenesis ontology), and invasion (ontologies: proteases and related, extracellular matrix (ECM), signal transduction, and cytoskeleton) were found to be differentially expressed in response to macrophage CM. Second, treatment of macrophages with CM from cultured endometrial stromal cells resulted in changes in the expression of genes in the macrophages, albeit a smaller number than with the converse treatment. Together, these data confirm our hypothesis that macrophages and endometrial stromal cells communicate with each other and that this communication, translated to the in vivo state, may contribute to the pathology of endometriosis. Although the number of differentially expressed genes in macrophages in response to treatment with endometrial stromal cell CM was not large, it is interesting to note that 5 genes were reciprocally upregulated in both cell types in response to CM from the other cell type. These data suggest the potential for positive feedback between the 2 cell types. Of the 5 genes, MMP3 has been proposed to be involved in the invasive processes of endometriosis. 21 A role for tumor necrosis factor a (TNF-a) in endometriosis has been proposed 22 ; one of its receptors, TNFR21, is another of the 5 genes for which positive feedback may occur between endometrial stromal cells and macrophages.
The list of genes that was differentially expressed in cultured endometrial cells treated with macrophage CM overlapped with the list of genes that was differentially expressed in endometriosis lesions reported previously. 15 The overlap of the 2 gene lists supports our hypothesis that communication between macrophages and endometrial stromal cells contributes to the pathology of endometriosis. As described further below, many of the genes that appear in both lists have been associated with endometriosis. However, it is also important to note that the list of overlapping genes included only 6% of each individual gene list. The endometriosis tissue samples were obtained from well-established lesions that had been chronically exposed to the inflammatory conditions of the lesion, whereas the cultured endometrial stromal cells were newly exposed to the factors secreted by macrophages, so the cellular responses may be different based on the time of exposure. Moreover, endometriosis lesions are composed of multiple cell types including endometrial stromal and epithelial cells, vascular cells, and various types of leukocytes, whereas the cultured cells are composed of a single cell type, so the cultured cells can only express a partial response compared to the multicellular lesion. In addition, it has been reported that the peritoneal mesothelial cells lining the peritoneal cavity interact with endometrial cells in a model of early development of endometriosis and that this interaction results in changes in gene expression in both cell types. 23 This interaction most likely also contributes to the gene expression changes in endometriosis that do not overlap with the genes reported here for cultured endometrial stromal cells.
Cysteine-rich angiogenic inducer 61/CCN1, CTGF/CCN2, and TNC are all matricellular proteins of the ECM that do not have a structural role. 24 Rather, matricellular proteins are adaptors and modulators of cell-ECM interactions. They interact with and integrate subsets of the actions of cytokines, growth factors, proteases, ECM structural proteins, and cell adhesion receptors in a cell type-specific manner. 24 CYR61/CCN1 and CTGF/CCN2 support a number of functions associated with endometriosis including cell adhesion, cell migration, and angiogenesis. 24 CTGF/CCN2 is known to synergize with transforming growth factor b (TGF-b) in the synthesis of ECM proteins during normal wound healing and in pathological fibrosis. 25, 26 An interaction between CTGF/CCN2 and TGF-b may be responsible for the fibrosis that occurs in endometriotic lesions. 1 Both CTGF/ CCN2 15 and CYR61/CCN1 27, 28 have been associated with endometriosis. Upregulation of TNC has also been reported in endometriosis. 15, 29, 30 Tenascin C is associated with cellular functions associated with endometriosis such as migration and invasion, angiogenesis, 31, 32 and cell proliferation. 31 Cleavage of components of the ECM such as collagen by MMPs is believed to play an important role in the remodeling of the ECM 33,34 that allows endometrial cells to invade the peritoneum during the establishment of endometriosis lesions. 21 In addition, MMPs may release active growth factors and cytokines from inactive precursors that are bound to the ECM 34 and which may also contribute to the development of endometriosis. Moreover, suppression of MMP expression with E þ P reduced the formation of endometriosis-like lesions in the nude mouse model of endometriosis. 35 Thus, our finding that macrophage CM stimulates the expression of MMPs 1 and 3 in cultured endometrial cells, and that MMP 1 and 3 expression was decreased by treatment with E þ P, support the hypothesis that communication between macrophages and endometrial cells may contribute to the pathology of endometriosis.
Interleukin 8, also known as chemokine CXCL8, is a chemotactic factor primarily for neutrophils and lymphocytes 36 B. C. Figure 3 . A, Overlap of genes in cultured endometrial cells that were differentially expressed in response to macrophage CM and genes that were differentially expressed in endometriosis. 15 B, Overlap of factors secreted by monocytes 12 versus factors secreted by macrophages. C, Overlap of genes in cultured endometrial cells that were differentially expressed in response to macrophage CM versus monocyte CM. 12 C1q and tumor necrosis factor-related protein 6 (C1QTNF6) c 2.49 nd NM_002995
Chemokine (C motif) ligand 1 (XCL1) c 9.51 nd NM_002990
Chemokine (C-C motif) ligand 22 (CCL22) c 56.91 nd NM_005064
Chemokine (C-C motif) ligand 23 (CCL23) c 4.15 nd NM_002991
Chemokine (C-C motif) ligand 24 (CCL24) c 8.72 nd NM_002985
Chemokine (C-C motif) ligand 5 (CCL5) c 98.65 nd NM_002996
Chemokine (C-X3-C motif) ligand 1 (CX3CL1) 3.72 nd NM_001511
Chemokine (C-X-C motif) ligand 1 (CXCL1) c 6.37 nd NM_002090
Chemokine (C-X-C motif) ligand 3 (CXCL3) 3.93 nd NM_016951
Chemokine-like factor (CKLF) c 89.05 nd NM_144601
Chemokine-like factor super family 3 (CKLFSF3) c 28.39 nd NM_138460
Chemokine-like factor super family 5 (CKLFSF5) c 8.62 nd NM_017801
Chemokine-like factor super family 6 (CKLFSF6) c 34 but has effects on other cell types as well. 37, 38 In addition, IL8/CXCL8 is a potent angiogenic factor. 39 Increases in IL8/CXCL8 expression have been reported in endometriosis, 40 and IL8/CXCL8 is significantly increased in peritoneal fluid of women with endometriosis. 41 Moreover, IL8/CXCL8 expression by cultured endometrial stromal cells has been reported. 42 Thus, our demonstration of increased IL8/CXCL8 expression in endometrial stromal cells in response to macrophage CM corroborates information in the literature. Our data also support the hypothesis that communication between macrophages and endometrial cells contributes to the pathology of endometriosis through stimulating neovascularization. The recruitment of neutrophils to the endometrial stromal cells by IL8/CXCL8 brings on board an additional cell type that is likely to contribute to the developing intercellular communication network and may further exacerbate the pathology of endometriosis.
Phospholamban was shown to be increased in endometriosis in a microarray study, 15 and in the current study, macrophage CM increased PLN in cultured endometrial stromal cells. Phospholamban suppresses the activity of the Ca 2þ -ATPase pump that returns cytoplasmic calcium levels to basal concentrations by pumping calcium into the endoplasmic reticulum (ER). 43 The primary focus of PLN research has been on cardiac muscle contractility because of the importance of returning calcium to the sarcoendoplasmic reticulum after each muscle contraction. 44 Recently, a new role for PLN has been proposed in cell survival. A decrease in calcium levels in the ER reduces the sensitivity of a cell to apoptosis, whereas an increase in ER calcium increases the sensitivity of the cell to apoptosis. [44] [45] [46] We can speculate that an increase in the expression of PLN in endometrial stromal cells in response to factors secreted by macrophages may reduce cellular sensitivity to apoptosis and support endometrial cell survival outside the uterus.
Nicotinamide N-methyltransferase is involved in the metabolism of xenobiotics 47 and its expression has been shown to be a prognostic indicator in cancer. 48 Nicotinamide N-methyltransferase is upregulated in endometriosis tissue 15 and is expressed in normal endometrium. 49 Recently, NNMT expression has been associated with increased cell migration and tumor invasion in bladder cancer cell lines. 50 The increased expression of NNMT in endometrial stromal cells treated with macrophage CM may be related to the migration and invasion of endometrial cells that occurs during the establishment of endometriosis.
Adhesion of endometrial cells to the peritoneum is an integral step in the establishment of endometriosis. 4, 51 Integrins are one of the large families of cell adhesive molecules 51, 52 and are considered important players in the adhesion of endometrial cells in the peritoneal cavity during the development of endometriosis. In addition to adhesion, ITGs act as mediators of signal transduction 52 as well as cell motility. 53 The expression of ITGA6 was shown to decrease in endometriosis 15, 54 and its expression is depolarized in the endometrium of women with endometriosis. 55 The reduction Papilin, proteoglycan-like sulfated glycoprotein (PAPLN) 5.22 nd a Statistical differences in gene expression between macrophages and monocytes were calculated by GeneSpring 7.3 software. b Fold expression compares macrophage secretion to monocyte secretion of the same factor. (Expression of secreted factor in macrophages divided by expression of the secreted factor in monocytes 12 . nd ¼ monocyte data not significantly different from macrophage data) c Data for monocyte-secreted factors has been reported previously. 12 d Expression values for secreted proteinases were not reported previously for monocytes. 12 
